While medical-grade, professional skin care is the go-to choice when it comes to recommending the most effective, clinical topical solutions to address patient skin concerns, there are some dermatologist-recommended over-the-counter skin care brands that have proven themselves worthy in this area time and again over the years. Brands like CeraVe, SkinFix, Neutrogena, La Roche-Posay and others provide patients with an affordable skin care option that has been thoroughly tested and approved by dermatologists when more expensive products are out of their price range. This allows practitioners to provide the best possible patient care when planning a skin care regimen to treat various skin health concerns no matter their wallet size. On top of that, these well-known dermatologist-recommended OTC skin care brands have demonstrated their value as effective topical solutions in their own right, and are important tools to have in one's skin care toolbox either way.
In our recent survey which asked, Would you like the latest information on dermatologist recommended OTC skin care brands? 91% of readers said yes and 9% said no.
Considering their value in providing affordable patient care options as well as proven and derm-approved topical skin care solutions, staying current on the latest information about advances in dermatologist-recommended OTC skin care brands is an important part of providing the best treatment available for the particular skin health, budgetary and other individual needs of each patient. Here are five informative MedEsthetics articles to help you do just that.
- CeraVe Highlights Acne Education with Clear It Up Like a Derm Campaign
- PanOxyl's Blemish Aftercare Brightening Patches Targets Dark Spots
- Neutrogena Hydro Boost Water Cream Strengthens the Skin Barrier with Long-lasting Hydration
- Valisure Files Citizen Petition for Market Withdrawl of Benzoyl Peroxide Products
- La Roche-Posay Becomes Official Sunscreen Partner of Miami Open
Check back every Tuesday for a new one-click survey.
We'll reveal the answers in next week's MedEsthetics newsletter.
